35.11
-0.6(-1.68%)
Currency In USD
| Previous Close | 35.71 |
| Open | 35.56 |
| Day High | 35.6 |
| Day Low | 34.41 |
| 52-Week High | 46.48 |
| 52-Week Low | 15.16 |
| Volume | 1.83M |
| Average Volume | 3.08M |
| Market Cap | 5.57B |
| PE | 140.44 |
| EPS | 0.25 |
| Moving Average 50 Days | 37.91 |
| Moving Average 200 Days | 31.09 |
| Change | -0.6 |
If you invested $1000 in TG Therapeutics, Inc. (TGTX) 10 years ago, it would be worth $2,143.47 as of June 01, 2025 at a share price of $35.11. Whereas If you bought $1000 worth of TG Therapeutics, Inc. (TGTX) shares 5 years ago, it would be worth $1,909.19 as of June 01, 2025 at a share price of $35.11.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting
GlobeNewswire Inc.
May 30, 2025 11:30 AM GMT
NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentations of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the 2025 Consortium
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting
GlobeNewswire Inc.
May 27, 2025 11:30 AM GMT
NEW YORK, May 27, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in patients with relapsing forms of multiple sclerosis (RMS), at t
TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update
GlobeNewswire Inc.
Apr 30, 2025 11:30 AM GMT
Conference call to be held Monday, May 5, 2025, at 8:30 AM ETNEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Monday, May 5, 2025, at 8:30 AM ET to discuss resul